Diisopropylethylamine → 2-Amino-4-[(S)-1-(6-fluoro-1-phenyl-1H-benzoimidazol-2-yl)-ethylamino]-pyrimidine-5-carbonitrile
Reaktionsgleichung
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:9]=[C:8]([C@@H:10]([NH2:12])[CH3:11])[N:7]([C:13]3[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=3)[C:6]=2[CH:19]=1.[NH2:20][C:21]1[N:26]=[C:25](Cl)[C:24]([C:28]#[N:29])=[CH:23][N:22]=1.CCN(C(C)C)C(C)C>CC(O)C.CO>[NH2:20][C:21]1[N:26]=[C:25]([NH:12][C@H:10]([C:8]2[N:7]([C:13]3[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=3)[C:6]3[CH:19]=[C:2]([F:1])[CH:3]=[CH:4][C:5]=3[N:9]=2)[CH3:11])[C:24]([C:28]#[N:29])=[CH:23][N:22]=1Komponenten
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
A mixture of (S)-1-(6-fluoro-1-phenyl-1H-benzoimidazol-2-yl)ethylamine.2HCl (85 mg, 0.259 mmol), 2-amino-4-chloropyrimidine-5-carbonitrile (40 mg, 0.26 mmol) and DIPEA (222 μL, 1.29 mmol) in IPA (0.75 mL) was heated at 90° C. in a sealed vial for 21 h. After cooling to RT, the crude mixture was diluted with MeOH and loaded into an Isolute®SCX-2 cartridge. The cartridge was washed with MeOH followed by 2M NH3/MeOH. The basic fractions were combined, concentrated in vacuo and the resulting residue purified by column chromatography (Si—PCC, gradient 0-100% EtOAc in DCM) followed by trituration from EtOAc/Et2O/cyclohexane to afford 362 as a white solid (61 mg, 63%). LCMS (Method K): RT 3.47 min [M+H]+ 374.02. 1H NMR (DMSO-d6, 400 MHz): δ 8.08 (1H, s), 7.74 (1H, dd, J=8.80, 4.85 Hz), 7.68 (1H, d, J=7.49 Hz), 7.58-7.52 (5H, m), 7.16-6.70 (4H, m), 5.51 (1H, m), 1.47 (3H, d, J=6.80 Hz)
Aufarbeitung
- washThe cartridge was washed with MeOH
- concentrationconcentrated in vacuo
- customthe resulting residue purified by column chromatography (Si—PCC, gradient 0-100% EtOAc in DCM)
Quellen und Nachweise
- ORD-Eintrag
- ord-2c8a707762df45739d45037c21354301
- Quelldatensatz
- uspto-grants-2014_02
- Patentnummer
- US08653089B2
Notizen zur Reaktion
Wird geladen…